SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 409 filers reported holding SAREPTA THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 1.18 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $97,751,772 | +48.2% | 806,400 | +40.1% | 0.67% | +58.9% |
Q2 2023 | $65,938,572 | -40.4% | 575,782 | -28.3% | 0.42% | -46.4% |
Q1 2023 | $110,630,405 | +13.6% | 802,658 | +6.8% | 0.78% | +4.1% |
Q4 2022 | $97,404,768 | +48.1% | 751,696 | +26.4% | 0.75% | +43.9% |
Q3 2022 | $65,751,000 | +38.1% | 594,816 | +112.9% | 0.52% | +84.5% |
Q4 2020 | $47,623,000 | -0.9% | 279,328 | -18.4% | 0.28% | -9.0% |
Q3 2020 | $48,049,000 | -0.8% | 342,155 | +13.2% | 0.31% | -6.6% |
Q2 2020 | $48,446,000 | +43.1% | 302,145 | -12.7% | 0.33% | +11.7% |
Q1 2020 | $33,854,000 | -19.6% | 346,086 | +6.1% | 0.30% | -0.7% |
Q4 2019 | $42,103,000 | +74.4% | 326,278 | +1.8% | 0.30% | +55.4% |
Q3 2019 | $24,145,000 | -42.0% | 320,561 | +17.1% | 0.19% | -38.3% |
Q2 2019 | $41,613,000 | +19.8% | 273,857 | -6.0% | 0.31% | +18.6% |
Q1 2019 | $34,742,000 | +24.8% | 291,487 | +14.3% | 0.26% | +11.4% |
Q4 2018 | $27,839,000 | +82.1% | 255,102 | +169.5% | 0.24% | +121.5% |
Q3 2018 | $15,288,000 | – | 94,655 | – | 0.11% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Ikarian Capital, LLC | 399,400 | $35,962,000 | 5.36% |
Avoro Capital Advisors LLC | 3,125,000 | $281,406,000 | 4.79% |
Varenne Capital Partners | 324,661 | $29,236,000 | 4.34% |
Evolutionary Tree Capital Management, LLC | 96,695 | $8,707,000 | 4.18% |
Ally Bridge Group (NY) LLC | 120,000 | $10,806,000 | 3.78% |
Casdin Capital, LLC | 1,350,000 | $121,568,000 | 3.43% |
Ghost Tree Capital, LLC | 100,000 | $9,005,000 | 3.23% |
GREAT POINT PARTNERS LLC | 145,405 | $13,094,000 | 2.91% |
Camber Capital Management LP | 825,000 | $74,291,000 | 2.55% |
Alpha DNA Investment Management LLC | 17,522 | $1,577,000 | 1.00% |